We found that levels of PP2A and demethylated PP2A were similar in AD P-tau injected hippocampus as compared with vehicle treatment in Tg/hTau and Tau−/− mice (Figures 6A,B), suggesting that PP2A may not be involved in AD P-tau-induced hyperphosphorylation of tau. Here, MAPT is linked to Alzheimer disease.